107 related articles for article (PubMed ID: 25759205)
1. A systemic Pasteurella multocida toxin aggravates cardiac hypertrophy and fibrosis in mice.
Weise M; Vettel C; Spiger K; Gilsbach R; Hein L; Lorenz K; Wieland T; Aktories K; Orth JH
Cell Microbiol; 2015 Sep; 17(9):1320-31. PubMed ID: 25759205
[TBL] [Abstract][Full Text] [Related]
2. The pasteurella multocida toxin interacts with signalling pathways to perturb cell growth and differentiation.
Lax AJ; Pullinger GD; Baldwin MR; Harmey D; Grigoriadis AE; Lakey JH
Int J Med Microbiol; 2004 Apr; 293(7-8):505-12. PubMed ID: 15149025
[TBL] [Abstract][Full Text] [Related]
3. Noncanonical G-protein-dependent modulation of osteoclast differentiation and bone resorption mediated by Pasteurella multocida toxin.
Strack J; Heni H; Gilsbach R; Hein L; Aktories K; Orth JH
mBio; 2014 Nov; 5(6):e02190. PubMed ID: 25389180
[TBL] [Abstract][Full Text] [Related]
4. Pasteurella multocida toxin-induced activation of RhoA is mediated via two families of G{alpha} proteins, G{alpha}q and G{alpha}12/13.
Orth JH; Lang S; Taniguchi M; Aktories K
J Biol Chem; 2005 Nov; 280(44):36701-7. PubMed ID: 16141214
[TBL] [Abstract][Full Text] [Related]
5. Pasteurella multocida toxin (PMT) upregulates CTGF which leads to mTORC1 activation in Swiss 3T3 cells.
Oubrahim H; Wong A; Wilson BA; Chock PB
Cell Signal; 2013 May; 25(5):1136-48. PubMed ID: 23415771
[TBL] [Abstract][Full Text] [Related]
6. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
7. Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility.
Sabri A; Wilson BA; Steinberg SF
Circ Res; 2002 May; 90(8):850-7. PubMed ID: 11988485
[TBL] [Abstract][Full Text] [Related]
8. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
9. Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways.
Preuss I; Hildebrand D; Orth JH; Aktories K; Kubatzky KF
Cell Microbiol; 2010 Aug; 12(8):1174-85. PubMed ID: 20331638
[TBL] [Abstract][Full Text] [Related]
10. Pasteurella multocida toxin activates Gbetagamma dimers of heterotrimeric G proteins.
Preuss I; Kurig B; Nürnberg B; Orth JH; Aktories K
Cell Signal; 2009 Apr; 21(4):551-8. PubMed ID: 19135527
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Osteocytes in the Action of
Heni H; Ebner JK; Schmidt G; Aktories K; Orth JHC
Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30104531
[No Abstract] [Full Text] [Related]
12. Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins.
Orth JH; Fester I; Siegert P; Weise M; Lanner U; Kamitani S; Tachibana T; Wilson BA; Schlosser A; Horiguchi Y; Aktories K
FASEB J; 2013 Feb; 27(2):832-42. PubMed ID: 23150526
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic actions of Pasteurella multocida toxin detected by monoclonal antibodies recognizing the deamidated α subunit of the heterotrimeric GTPase Gq.
Kamitani S; Ao S; Toshima H; Tachibana T; Hashimoto M; Kitadokoro K; Fukui-Miyazaki A; Abe H; Horiguchi Y
FEBS J; 2011 Aug; 278(15):2702-12. PubMed ID: 21624053
[TBL] [Abstract][Full Text] [Related]
14. Pasteurella multocida toxin prevents osteoblast differentiation by transactivation of the MAP-kinase cascade via the Gα(q/11)--p63RhoGEF--RhoA axis.
Siegert P; Schmidt G; Papatheodorou P; Wieland T; Aktories K; Orth JH
PLoS Pathog; 2013; 9(5):e1003385. PubMed ID: 23696743
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496
[TBL] [Abstract][Full Text] [Related]
16. Activation of Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin.
Orth JH; Fester I; Preuss I; Agnoletto L; Wilson BA; Aktories K
J Biol Chem; 2008 Aug; 283(34):23288-94. PubMed ID: 18583341
[TBL] [Abstract][Full Text] [Related]
17. Action of Pasteurella multocida toxin on Galpha(q) is persistent and independent of interaction with G-protein-coupled receptors.
Orth JH; Lang S; Preuss I; Milligan G; Aktories K
Cell Signal; 2007 Oct; 19(10):2174-82. PubMed ID: 17669624
[TBL] [Abstract][Full Text] [Related]
18. SmgGDS as a Crucial Mediator of the Inhibitory Effects of Statins on Cardiac Hypertrophy and Fibrosis: Novel Mechanism of the Pleiotropic Effects of Statins.
Kudo S; Satoh K; Nogi M; Suzuki K; Sunamura S; Omura J; Kikuchi N; Kurosawa R; Satoh T; Minami T; Ikeda S; Miyata S; Shimokawa H
Hypertension; 2016 May; 67(5):878-89. PubMed ID: 26975711
[TBL] [Abstract][Full Text] [Related]
19. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
[TBL] [Abstract][Full Text] [Related]
20. Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin.
Babb RC; Homer KA; Robbins J; Lax AJ
PLoS One; 2012; 7(11):e47188. PubMed ID: 23144805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
